Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 19 (RPL12P19)

Target: RPL12P19
Molecular classification: Other (pseudogene)

Overview

Ribosomal protein L12 pseudogene 19 (RPL12P19) is one of several processed pseudogenes of the functional RPL12 gene, which encodes the 60S ribosomal protein L12. Pseudogenes like RPL12P19 arise from duplication or retrotransposition events, followed by accumulation of mutations that render them non-functional. These pseudogenes are not expressed as proteins and are not considered drug targets or involved in any known biological processes or diseases. The canonical, functional gene RPL12 encodes a cytoplasmic component of the ribosome involved in protein synthesis, but this description does not apply to its pseudogenes[3][4][5].

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 19 (RPL12P19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 19 (RPL12P19).

Explore the full profile